These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20091428)

  • 1. Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation.
    Shineha R; Kawakami M; Kawakami K; Nagata M; Tada T; Kato K
    Stem Cell Rev Rep; 2010 Mar; 6(1):1-7. PubMed ID: 20091428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cells.
    Sawai T; Hatta T; Fujita M
    Regen Med; 2017 Apr; 12(3):233-248. PubMed ID: 28332949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of commercialisation on public perceptions of stem cell research: exploring differences across the use of induced pluripotent cells, human and animal embryos.
    Critchley CR; Bruce G; Farrugia M
    Stem Cell Rev Rep; 2013 Oct; 9(5):541-54. PubMed ID: 23695820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - A pilot study.
    Shineha R; Inoue Y; Yashiro Y
    Regen Ther; 2022 Jun; 20():187-193. PubMed ID: 35620641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What can be learnt from the Japanese regulatory approach to tissue engineered products?
    Brévignon-Dodin L; Livesey F
    Regen Med; 2007 Nov; 2(6):967-71. PubMed ID: 18034634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It's about change...regenerative medicine in the Obama era.
    Klein RN; Doyle J; Siegel B
    Regen Med; 2009 Jan; 4(1):27-32. PubMed ID: 19250058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How physicians and scientists can respond responsibly and effectively to religiously based opposition to human embryonic stem cell research.
    Chervenak FA; McCullough LB
    Fertil Steril; 2008 Dec; 90(6):2056-9. PubMed ID: 18178193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising new sources for pluripotent stem cells.
    Leeb C; Jurga M; McGuckin C; Moriggl R; Kenner L
    Stem Cell Rev Rep; 2010 Mar; 6(1):15-26. PubMed ID: 20091142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Social Framework Surrounding the Development of Regenerative Medicine in Japan.
    Nakazawa E; Takimoto Y; Akabayashi A
    Camb Q Healthc Ethics; 2016 Jul; 25(3):466-71. PubMed ID: 27348830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Japanese initiatives on stem cell therapies.
    Konomi K; Tobita M; Kimura K; Sato D
    Cell Stem Cell; 2015 Apr; 16(4):350-2. PubMed ID: 25842974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NerveCenter: Are IPSCs a game-changer in stem cell debate?
    Stone K
    Ann Neurol; 2010 Nov; 68(5):A9-A10. PubMed ID: 21031569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Stem Cells Transl Med; 2018 Feb; 7(2):251-257. PubMed ID: 29372590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan.
    Okada K; Miyata T; Sawa Y
    Regen Med; 2017 Mar; 12(2):179-186. PubMed ID: 28244828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
    Hsu YC; Wu YT; Tsai CL; Wei YH
    Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.